1-21889786-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005529.7(HSPG2):​c.574+195G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.31 in 630,300 control chromosomes in the GnomAD database, including 31,697 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6637 hom., cov: 32)
Exomes 𝑓: 0.32 ( 25060 hom. )

Consequence

HSPG2
NM_005529.7 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.72

Publications

11 publications found
Variant links:
Genes affected
HSPG2 (HGNC:5273): (heparan sulfate proteoglycan 2) This gene encodes the perlecan protein, which consists of a core protein to which three long chains of glycosaminoglycans (heparan sulfate or chondroitin sulfate) are attached. The perlecan protein is a large multidomain proteoglycan that binds to and cross-links many extracellular matrix components and cell-surface molecules. It has been shown that this protein interacts with laminin, prolargin, collagen type IV, FGFBP1, FBLN2, FGF7 and transthyretin, etc., and it plays essential roles in multiple biological activities. Perlecan is a key component of the vascular extracellular matrix, where it helps to maintain the endothelial barrier function. It is a potent inhibitor of smooth muscle cell proliferation and is thus thought to help maintain vascular homeostasis. It can also promote growth factor (e.g., FGF2) activity and thus stimulate endothelial growth and re-generation. It is a major component of basement membranes, where it is involved in the stabilization of other molecules as well as being involved with glomerular permeability to macromolecules and cell adhesion. Mutations in this gene cause Schwartz-Jampel syndrome type 1, Silverman-Handmaker type of dyssegmental dysplasia, and tardive dyskinesia. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
HSPG2 Gene-Disease associations (from GenCC):
  • Schwartz-Jampel syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Silverman-Handmaker type dyssegmental dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • Schwartz-Jampel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-21889786-C-T is Benign according to our data. Variant chr1-21889786-C-T is described in ClinVar as Benign. ClinVar VariationId is 1293470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.378 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSPG2NM_005529.7 linkc.574+195G>A intron_variant Intron 6 of 96 ENST00000374695.8 NP_005520.4 P98160

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSPG2ENST00000374695.8 linkc.574+195G>A intron_variant Intron 6 of 96 1 NM_005529.7 ENSP00000363827.3 P98160
HSPG2ENST00000374673.4 linkc.328+195G>A intron_variant Intron 3 of 6 3 ENSP00000497688.1 A0A3B3IT11
HSPG2ENST00000412328.5 linkn.342+195G>A intron_variant Intron 3 of 5 2
HSPG2ENST00000439717.2 linkn.*30G>A downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.283
AC:
42994
AN:
151900
Hom.:
6632
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.172
Gnomad AMI
AF:
0.469
Gnomad AMR
AF:
0.386
Gnomad ASJ
AF:
0.226
Gnomad EAS
AF:
0.380
Gnomad SAS
AF:
0.298
Gnomad FIN
AF:
0.332
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.312
Gnomad OTH
AF:
0.280
GnomAD4 exome
AF:
0.319
AC:
152376
AN:
478280
Hom.:
25060
Cov.:
5
AF XY:
0.318
AC XY:
79840
AN XY:
251378
show subpopulations
African (AFR)
AF:
0.170
AC:
2222
AN:
13080
American (AMR)
AF:
0.450
AC:
9428
AN:
20938
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
3314
AN:
14174
East Asian (EAS)
AF:
0.396
AC:
12321
AN:
31084
South Asian (SAS)
AF:
0.317
AC:
14703
AN:
46386
European-Finnish (FIN)
AF:
0.345
AC:
15263
AN:
44178
Middle Eastern (MID)
AF:
0.270
AC:
962
AN:
3562
European-Non Finnish (NFE)
AF:
0.310
AC:
86161
AN:
278048
Other (OTH)
AF:
0.298
AC:
8002
AN:
26830
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
5128
10256
15384
20512
25640
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
580
1160
1740
2320
2900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.283
AC:
43011
AN:
152020
Hom.:
6637
Cov.:
32
AF XY:
0.286
AC XY:
21235
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.172
AC:
7143
AN:
41476
American (AMR)
AF:
0.387
AC:
5902
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
785
AN:
3470
East Asian (EAS)
AF:
0.380
AC:
1954
AN:
5146
South Asian (SAS)
AF:
0.298
AC:
1435
AN:
4818
European-Finnish (FIN)
AF:
0.332
AC:
3503
AN:
10566
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.312
AC:
21205
AN:
67956
Other (OTH)
AF:
0.277
AC:
587
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1531
3062
4592
6123
7654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.296
Hom.:
11406
Bravo
AF:
0.280
Asia WGS
AF:
0.318
AC:
1108
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.23
DANN
Benign
0.72
PhyloP100
-1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3767141; hg19: chr1-22216279; COSMIC: COSV107487800; COSMIC: COSV107487800; API